245 related articles for article (PubMed ID: 28749949)
1. 2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.
Jeon AB; Obregón-Henao A; Ackart DF; Podell BK; Belardinelli JM; Jackson M; Nguyen TV; Blackledge MS; Melander RJ; Melander C; Johnson BK; Abramovitch RB; Basaraba RJ
PLoS One; 2017; 12(7):e0180925. PubMed ID: 28749949
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics.
Flores AR; Parsons LM; Pavelka MS
Microbiology (Reading); 2005 Feb; 151(Pt 2):521-532. PubMed ID: 15699201
[TBL] [Abstract][Full Text] [Related]
3. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
Dinçer I; Ergin A; Kocagöz T
Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis and beta-lactam antibiotics.
Gun MA; Bozdogan B; Coban AY
Future Microbiol; 2020 Jul; 15():937-944. PubMed ID: 32762449
[TBL] [Abstract][Full Text] [Related]
5. The Discovery of 2-Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β-Lactam Antibiotics in a Pattern Distinct from β-Lactamase Inhibitors.
Nguyen TV; Blackledge MS; Lindsey EA; Minrovic BM; Ackart DF; Jeon AB; Obregón-Henao A; Melander RJ; Basaraba RJ; Melander C
Angew Chem Int Ed Engl; 2017 Mar; 56(14):3940-3944. PubMed ID: 28247991
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
Wang F; Cassidy C; Sacchettini JC
Antimicrob Agents Chemother; 2006 Aug; 50(8):2762-71. PubMed ID: 16870770
[TBL] [Abstract][Full Text] [Related]
7. 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain.
Jeon AB; Ackart DF; Li W; Jackson M; Melander RJ; Melander C; Abramovitch RB; Chicco AJ; Basaraba RJ; Obregón-Henao A
Sci Rep; 2019 Feb; 9(1):1513. PubMed ID: 30728417
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis.
Wivagg CN; Bhattacharyya RP; Hung DT
J Antibiot (Tokyo); 2014 Sep; 67(9):645-54. PubMed ID: 25052484
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the β-Lactams for Tuberculosis Therapy with a Compound-Compound Synthetic Lethality Approach.
Xiao S; Guo H; Weiner WS; Maddox C; Mao C; Gunosewoyo H; Pelly S; White EL; Rasmussen L; Schoenen FJ; Aubé J; Bishai WR; Lun S
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427291
[TBL] [Abstract][Full Text] [Related]
10. Analogue synthesis reveals decoupling of antibiofilm and β-lactam potentiation activities of a lead 2-aminoimidazole adjuvant against Mycobacterium smegmatis.
Martin SE; Nguyen CM; Basaraba RJ; Melander C
Chem Biol Drug Des; 2018 Aug; 92(2):1403-1408. PubMed ID: 29663670
[TBL] [Abstract][Full Text] [Related]
11. Collateral Sensitivity to β-Lactam Drugs in Drug-Resistant Tuberculosis Is Driven by the Transcriptional Wiring of BlaI Operon Genes.
Trigos AS; Goudey BW; Bedő J; Conway TC; Faux NG; Wyres KL
mSphere; 2021 Jun; 6(3):e0024521. PubMed ID: 34047652
[TBL] [Abstract][Full Text] [Related]
12. Structures of
Lu Z; Wang H; Zhang A; Liu X; Zhou W; Yang C; Guddat L; Yang H; Schofield CJ; Rao Z
Mol Pharmacol; 2020 Apr; 97(4):287-294. PubMed ID: 32086254
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics.
Cohen KA; El-Hay T; Wyres KL; Weissbrod O; Munsamy V; Yanover C; Aharonov R; Shaham O; Conway TC; Goldschmidt Y; Bishai WR; Pym AS
EBioMedicine; 2016 Jul; 9():170-179. PubMed ID: 27333036
[TBL] [Abstract][Full Text] [Related]
14. A novel method for evaluating the outer membrane permeability to beta-lactamase-stable beta-lactam antibiotics.
Kojo H; Shigi Y; Nishida M
J Antibiot (Tokyo); 1980 Mar; 33(3):310-6. PubMed ID: 6991466
[TBL] [Abstract][Full Text] [Related]
15. Contribution of beta-lactamases to beta-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Segura C; Salvadó M; Collado I; Chaves J; Coira A
Antimicrob Agents Chemother; 1998 Jun; 42(6):1524-6. PubMed ID: 9624510
[TBL] [Abstract][Full Text] [Related]
16. Penicillin Binding Proteins and β-Lactamases of Mycobacterium tuberculosis: Reexamination of the Historical Paradigm.
Kumar G; Galanis C; Batchelder HR; Townsend CA; Lamichhane G
mSphere; 2022 Feb; 7(1):e0003922. PubMed ID: 35196121
[TBL] [Abstract][Full Text] [Related]
17. C4-alkylthiols with activity against Moraxella catarrhalis and Mycobacterium tuberculosis.
Kostova MB; Myers CJ; Beck TN; Plotkin BJ; Green JM; Boshoff HI; Barry CE; Deschamps JR; Konaklieva MI
Bioorg Med Chem; 2011 Nov; 19(22):6842-52. PubMed ID: 22014754
[TBL] [Abstract][Full Text] [Related]
18. Resuscitation-promoting factors are required for β-lactam tolerance and the permeability barrier in Mycobacterium tuberculosis.
Wivagg CN; Hung DT
Antimicrob Agents Chemother; 2012 Mar; 56(3):1591-4. PubMed ID: 22155826
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Zhang D; Wang Y; Lu J; Pang Y
Antimicrob Agents Chemother; 2016 Jan; 60(1):393-9. PubMed ID: 26525785
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of the transpeptidase domain of the Mycobacterium tuberculosis penicillin-binding protein PonA1 reveal potential mechanisms of antibiotic resistance.
Filippova EV; Kieser KJ; Luan CH; Wawrzak Z; Kiryukhina O; Rubin EJ; Anderson WF
FEBS J; 2016 Jun; 283(12):2206-18. PubMed ID: 27101811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
